Proteomic analysis of breast cancer cell lines MCF_7 and MDA_MB_468 treated with melatonin
Ontology highlight
ABSTRACT: Breast cancer (BC) is the most prevalent and lethal tumor among women worldwide.
Although the antitumor effects of melatonin are well documented, its precise molecular
mechanisms in specific breast cancer subtypes remain unclear. This dataset provides
proteomic data from total protein extracts of two breast cancer cell lines [MCF-7
(ER+and PR+) and MDA-MB-468 (triple negative) treated with melatonin. The aim of
the study was to identify melatonin-induced changes in global protein expression and to
assess its potential as a therapeutic modulator in hormone-responsive and triple-negative
breast cancer.
INSTRUMENT(S): Q-Exactive (Thermo Fisher)
ORGANISM(S): Homo Sapiens (ncbitaxon:9606)
SUBMITTER:
Roberta Carvalho Cesario
Luiz Gustavo de Almeida Chuffa
Debora Aparecida Pires de Campos Zuccari
Lucilene Delazari dos Santos
PROVIDER: MSV000098219 | MassIVE | Mon Jun 16 11:26:00 BST 2025
REPOSITORIES: MassIVE
ACCESS DATA